4.7 Letter

On the Usefulness of Outcome-Adaptive Randomization

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 29, Issue 13, Pages E390-E392

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2010.34.5330

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Statistics & Probability

Bayesian Hierarchical Model for Change Point Detection in Multivariate Sequences

Huaqing Jin, Guosheng Yin, Binhang Yuan, Fei Jiang

Summary: Motivated by wind turbine anomaly detection, a Bayesian hierarchical model (BHM) is proposed for mean-change detection in multivariate sequences. BHM combines a random order distribution induced from the Poisson-Dirichlet process and nonlocal priors, exhibiting satisfactory performance for mean-shift detection. The method yields the smallest detection error and outperforms other competitive methods for wind turbine anomaly detection in terms of the F1 score.

TECHNOMETRICS (2022)

Article Statistics & Probability

Reconstructing the Kaplan-Meier Estimator as an M-estimator

Jiaqi Gu, Yiwei Fan, Guosheng Yin

Summary: The Kaplan-Meier estimator, a nonparametric estimate for event survival functions, is restructured as an M-estimator through maximizing an M-function based on concordance, providing a new interpretation and establishing the limiting distribution. Empirical results demonstrate that the proposed M-estimator is equivalent to the KM estimator and can derive confidence intervals and bands.

AMERICAN STATISTICIAN (2022)

Article Statistics & Probability

Response-adaptive rerandomization

Hengtao Zhang, Guosheng Yin

Summary: Rerandomization is gaining attention in literature for randomized experiments due to its ability to achieve balanced allocation using covariate information, but it may raise ethical concerns. A response-adaptive rerandomization scheme is proposed for two-arm comparative clinical trials, showing promising statistical and ethical properties. Extensive simulation studies demonstrate the practicality and superiority of this approach.

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2021)

Article Mathematical & Computational Biology

Unit information prior for adaptive information borrowing from multiple historical datasets

Huaqing Jin, Guosheng Yin

Summary: In clinical trials, incorporating historical data in the analysis is crucial for gaining more information, improving efficiency, and providing a comprehensive evaluation of treatment. The new informative prior UIP can adaptively borrow information from multiple historical datasets, and is intuitive, easy to implement, and requires only summary statistics commonly reported in the literature.

STATISTICS IN MEDICINE (2021)

Review Public, Environmental & Occupational Health

Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Chenyang Zhang, Huaqing Jin, Yi Feng Wen, Guosheng Yin

Summary: This network meta-analysis evaluated the efficacy of various treatments for COVID-19 compared to standard care, showing superiority in terms of mortality, mechanical ventilation, hospital discharge, and viral clearance. Tocilizumab was found to be particularly effective in preventing severe outcomes and increasing discharge rates. Additionally, the study highlighted the clinical efficacy of antineoplastic agents, immunostimulants, and immunosuppressants in reducing mortality, ventilation risk, and increasing discharge rates, providing valuable information for potential COVID-19 treatments.

FRONTIERS IN PUBLIC HEALTH (2021)

Article Health Care Sciences & Services

CFO: Calibration-free odds design for phase I/II clinical trials

Huaqing Jin, Guosheng Yin

Summary: Recent developments in oncology treatment have focused on targeted therapy and immunotherapy, with a shift towards more tolerable treatments that prioritize efficacy. The calibration-free odds (CFO) design presented in this study offers a model-free approach for determining optimal biological dose (OBD) in cancer trials. Extensive simulation studies show that CFO strikes a good balance between efficiency and safety for identifying maximum tolerated dose (MTD) in phase I trials and performs comparably or slightly better for OBD identification in phase I/II trials compared to other methods.

STATISTICAL METHODS IN MEDICAL RESEARCH (2022)

Article Statistics & Probability

Sparse concordance-based ordinal classification

Yiwei Fan, Jiaqi Gu, Guosheng Yin

Summary: Ordinal classification is an important area in machine learning, aiming to accurately predict the relative order of instances. We propose a novel concordance-based approach that incorporates variable selection and penalized optimization for sparsity considerations.

SCANDINAVIAN JOURNAL OF STATISTICS (2023)

Article Statistics & Probability

Divide and conquer for accelerated failure time model with massive time-to-event data

Wen Su, Guosheng Yin, Jing Zhang, Xingqiu Zhao

Summary: Big data presents both theoretical and computational challenges as well as tremendous opportunities in various fields. In healthcare research, a novel approach called divide-and-conquer (DAC) is developed to handle massive and high-dimensional data. The proposed DAC method performs well and is applied to a large dataset from the Chinese Longitudinal Healthy Longevity Survey.

CANADIAN JOURNAL OF STATISTICS-REVUE CANADIENNE DE STATISTIQUE (2023)

Article Health Care Sciences & Services

Approximate Bayesian computation design for phase I clinical trials

Huaqing Jin, Wenbin Du, Guosheng Yin

Summary: In the development of new cancer treatments, determining the maximum tolerated dose in a phase I trial is crucial. Different approaches, such as model-based and algorithm-based designs, have their own strengths and weaknesses. The proposed approximate Bayesian computation design offers a more efficient and model-independent method for dose assignment in phase I trials.

STATISTICAL METHODS IN MEDICAL RESEARCH (2022)

Article Health Care Sciences & Services

Unit information prior for incorporating real-world evidence into randomized controlled trials

Hengtao Zhang, Guosheng Yin

Summary: Randomized controlled trials (RCTs) are considered the gold standard for clinical research on treatment effects. Recent interest has focused on integrating real-world evidence from observational studies to enhance and complement RCT results. The unit information prior (UIP) is a newly proposed technique that effectively incorporates information from historical datasets. We extend this approach to synthesize non-randomized evidence into current RCTs, improving statistical efficiency in estimating treatment effects for different outcome variables.

STATISTICAL METHODS IN MEDICAL RESEARCH (2023)

Article Statistics & Probability

PCA Rerandomization

Hengtao Zhang, Guosheng Yin, Donald B. Rubin

Summary: The Mahalanobis distance of covariate means is commonly used to achieve balance in rerandomization strategies. However, this criterion might not work well for high-dimensional cases as it treats all orthogonalized covariates equally. To address this issue, we propose using PCA to identify relevant subspaces for calculating Mahalanobis distance. PCA not only reduces dimensionality but also simplifies computation by focusing on the top orthogonal components. Our PCA rerandomization approach improves covariate balance and enhances the estimation of average treatment effects, as demonstrated in numerical studies with simulated and real data.

CANADIAN JOURNAL OF STATISTICS-REVUE CANADIENNE DE STATISTIQUE (2023)

Article Pharmacology & Pharmacy

Time-to-event calibration-free odds design: A robust efficient design for phase I trials with late-onset outcomes

Huaqing Jin, Guosheng Yin

Summary: Compared with existing phase I designs, the recently proposed calibration-free odds (CFO) design is robust, model-free, and easy to use. However, the original CFO design cannot handle late-onset toxicities commonly encountered in phase I oncology trials. To address this issue, we extend the CFO design to its time-to-event (TITE) version, which maintains the calibration-free and model-free properties. The TITE-CFO design performs robustly and efficiently compared to interval-based and model-based designs.

PHARMACEUTICAL STATISTICS (2023)

Article Health Care Sciences & Services

Omnibus test for restricted mean survival time based on influence function

Jiaqi Gu, Yiwei Fan, Guosheng Yin

Summary: The restricted mean survival time (RMST) is widely used to summarize survival distribution due to its robustness and interpretation. In comparative studies, the RMST-based test is used as an alternative to the log-rank test. We developed an RMST-based omnibus Wald test to detect survival differences between two groups throughout the study follow-up period, considering multiple quantile-based time points.

STATISTICAL METHODS IN MEDICAL RESEARCH (2023)

Article Health Care Sciences & Services

Quasi-rerandomization for observational studies

Hengtao Zhang, Wen Su, Guosheng Yin

Summary: This article proposes a method called quasi-rerandomization, which improves covariate balance by rerandomizing observational covariates, thus approximating randomized experiments. Through extensive numerical studies, the method demonstrates competitive performance in terms of improving covariate balance and precision of treatment effect estimation.

BMC MEDICAL RESEARCH METHODOLOGY (2023)

Article Statistics & Probability

SUBGROUP ANALYSIS IN CENSORED LINEAR REGRESSION

Xiaodong Yan, Guosheng Yin, Xingqiu Zhao

Summary: The proposed method offers a new approach to handling treatment heterogeneity with unknown grouping information, allowing for the identification of subgroup structures and estimation of subgroup-specific treatment effects simultaneously. By combining the Buckley-James iterative procedure and the alternating direction method of multipliers, the method demonstrates good performance in simulation studies and real-data applications.

STATISTICA SINICA (2021)

No Data Available